ELFUNAT
Back to ProductsA prescription drug that affects the nervous system. Antioxidant, antihypoxant and membrane protector.
Solution for injection
Articles
- Efficiency of methods of postoperative correction of metabolic homeostasis in patients with acute peritonitis Published in a journal «Pain, Anaesthesia and Intensive Care» № 2 (83)’2018
- Elfunate in the treatment of patients with discirculatory encephalopathy Published in the journal «Neurology and Neurosurgery. Eastern Europe» Vol 7 № 3’2017
- Combined therapy with Medotilin and Elfunat in the prevention and treatment of neuropsychiatric complications after open heart surgery Regional Center of Cardiosurgery of Odesa Regional Hospital, Odesa, Ukraine
- Features of management of patients with community-acquired pneumonia with concomitant pathology: substantiation of the advisability of using antihypoxants on the example of ethylmethylhydrox Published in a journal «Emergency Medicine» Vol 17 № 5’2021
- Elfunat in the holiatry of patients with portal gipertenziey in an early postgemorragicheskom period Published in the journal «Emergency Medicine» Vol 17 № 3’2021
- Features of cognitive violations at COVID-19 Published in the journal «International neurological journal» Vol 17 № 3’2021
- Use of Medotilin and Elfunat in acute and subacute period of ischemic stroke Published in a journal «Neurology and neurosurgery. Eastern Europe» Vol 7 № 3’2017
- Possibilities of neuroprotection in the complex therapy of traumatic brain injury Published in the journal “Emergency Medicine” № 7 (78) '2016
SPC
ELFUNAT
SPC — PDF